编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
171454 | 1-(4-溴-6-甲基吡啶-2-基)乙-1-酮 | 1060810-24-3 | ≧98.0% | |
1-(4-溴-6-甲基吡啶-2-基)乙-1-酮, CAS 1060810-24-3. | ||||
20471 | FHD-286 | 2671128-05-3 | ≧98.0% | |
FHD-286 is an oral, small-molecule, selective, allosteric inhibitor of BRG1 and BRM i | ||||
184163 | 2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile | 1032570-98-1 | >96% | |
2-amino-3-methoxy-4-(3-morpholin-4-ylpropoxy)benzonitrile是一种药物中间体。 | ||||
20657 | Zilurgisertib | 2173389-57-4 | ≧98.0% | |
Zilurgisertib(之前称为 INCB 00928)是一种激活素受体样激酶 2(ALK2, | ||||
237071 | Flavopiridol ( 夫拉平度 ) | 146426-40-6 | ≧98.0% | |
Alvocidib is a synthetic dihydroxyflavone that is 5,7-dihydroxyflavone which is subst | ||||
20266 | Linzagolix | 935283-04-8 | ≧98.0% | |
Linzagolix 是一种新型的口服 GnRH 受体拮抗剂,可有效治疗子宫内膜 | ||||
20549 | STC-15 | 2648257-56-9 | ≧98.0% | |
STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
24107 | LXH-3-71 | 2251753-65-6 | ≧97.0% | |
LXH-3-71是一种新型“分子胶”,可诱导PHGDH和DDB1-CUL4泛素连接酶之 | ||||
51802 | TIC10 ( ONC201 ) | 1616632-77-9 | 99.85% | |
ONC201 / TIC10是人类TRAIL基因的新型小分子诱导剂,可改善重组TRAIL的 | ||||
23122601 | Navacaprant | 2244614-14-8 | ≧98.0% | |
Navacaprant (NMRA-335140, BTRX-140) 是一种口服、选择性、可逆的 kappa 阿 | ||||
20509 | GLPG3667 | 2308520-97-8 | ≧98.0% | |
GLPG3667 是一种口服强效选择性小分子 TYK2 抑制剂,正在开发用于治 | ||||
121431 | KW-2478 | 819812-04-9 | 98% | |
KW-2478 是一种针对人类热休克蛋白 90 (Hsp90) 的药物,具有潜在的抗 |